Cargando…
Mucosal Immunization and Adjuvants
The goal of the influenza vaccine is to prevent influenza virus infection and control the yearly seasonal epidemic and pandemic. However, the presently available parenteral influenza vaccine induces only systemic humoral immunity, which does not prevent influenza virus infection on the mucosal surfa...
Autores principales: | Hasegawa, Hideki, van Reit, Elly, Kida, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120566/ https://www.ncbi.nlm.nih.gov/pubmed/25015787 http://dx.doi.org/10.1007/82_2014_402 |
Ejemplares similares
-
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009) -
The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants
por: Kim, Sae-Hae, et al.
Publicado: (2017) -
New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development
por: Kurashima, Yosuke, et al.
Publicado: (2014) -
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020) -
Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)